Dec 10 (Reuters) - A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial treatments, potentially allowing patients to avoid grueling bone marrow transplants, preliminary data from a small mid-stage trial suggest. Patients in the trial had received initial treatments that eliminated nearly all of their cancer cells.

Making a trip to Europe offers an abundance of social encounters, dazzling engineering, and various scenes. Whether you're searching for verifiable tourist spots,

Same engine, yes. But test-riding the brand’s new 400s in Spain, I couldn’t believe how different they felt.